• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Teva Pharmaceutical Industries Limited (TEVA)

    -NYQ
    58.00 Up 1.35(2.38%) Dec 19, 4:09PM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income 1,269,000   1,963,000   2,759,000  
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation1,642,000  1,708,000  1,069,000  
    Adjustments To Net Income(626,000)540,000  (297,000)
    Changes In Accounts Receivables -   -   -  
    Changes In Liabilities -   -   -  
    Changes In Inventories -   -   -  
    Changes In Other Operating Activities968,000  414,000  594,000  
    Total Cash Flow From Operating Activities 3,237,000   4,572,000   4,134,000  
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(1,031,000)(1,104,000)(1,053,000)
    Investments(160,000)(201,000)(217,000)
    Other Cash flows from Investing Activities44,000  171,000  (6,331,000)
    Total Cash Flows From Investing Activities (1,147,000) (1,134,000) (7,601,000)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid(1,089,000)(855,000)(800,000)
    Sale Purchase of Stock(406,000)(1,147,000)(903,000)
    Net Borrowings(2,411,000)319,000  5,034,000  
    Other Cash Flows from Financing Activities23,000  5,000  5,000  
    Total Cash Flows From Financing Activities (3,883,000) (1,678,000) 3,336,000  
    Effect Of Exchange Rate Changes(48,000)23,000  (21,000)
    Change In Cash and Cash Equivalents (1,841,000) 1,783,000   (152,000)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.